Home
Conditions
Recurrence

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies

Refine in advanced search Browse all conditions

Recurrence trial results

Not Yet Recruiting

BV in the Treatment of Relapsed/refractory Hodgkin Lymphoma

NCT06761911

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer

NCT06751277

Conditions: Disease Attributes, Endometrial Neoplasms, Female Urogenital Diseases, +14 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Ivonescimab Combined with Chemotherapy As First-line Treatment of Relapsed or Metastatic Thymic Cancer: a Prospective, Single Arm, Phase II Trial

NCT06750952

Conditions: Disease Attributes, First-line Treatment, Hemic and Lymphatic Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase II Study of SYHA1813 for Recurrent or Progressive High-Grade Meningioma

NCT06739213

Conditions: Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Predicting Treatment Failure in HSIL Patients with Positive Margins After Conization Via Detection of PAX1 Methylation

NCT06713655

Conditions: Cervical Conization, Disease Attributes, Female Urogenital Diseases, +21 more
Locations: Women's Hospital School Of Medicine Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.).

NCT06719479

Conditions: Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

WL276 CAR-T Cell Therapy for CD276 Positive Recurrent or Progressive Glioblastoma Patients

NCT06691308

Conditions: Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer

NCT06648200

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Disease Attributes, +13 more
Locations: Shanghai Pulmonary Hospital Shanghai, China

View Trial Details

Not Yet Recruiting

CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors

NCT06647329

Conditions: CAR-T Cell Therapy, Disease Attributes, Hemic and Lymphatic Diseases, +11 more
Locations: the First Hospital of Zhengzhou University Zhengzhou, Henan, China

View Trial Details

Not Yet Recruiting

A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined with Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation.

NCT06641648

Conditions: Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia (AML) Relapse, Disease Attributes, +11 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

View Trial Details

Recurrence

Recurrence trial results

Related conditions